Mauna Kea Technologies

Report Publication Announcement • Jan 11, 2021

Mauna Kea Technologies Announces its 2021 Financial Calendar

Paris and Boston, January 11, 2020 – 5.45 PM CET – Mauna Kea Technologies(Euronext: MKEA,) inventor of Cellvizio®, the multidisciplinary probe- and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform, today announced the publication of its 2021 Financial Calendar.

Event	Date*
2020 Fourth-Quarter and Full-Year Sales	January 21, 2021
2020	March 25,
Full-Year Financial Results	2021
2021	April 22,
First-Quarter Sales	2021
2021	July 22,
Second-Quarter and First-Half Sales	2021
2021	September 23,
First-Half Financial Results	2021
2021	October 21,
Third-Quarter Sales	2021

* Subject to modification. Press releases are published after market closes.

About Mauna Kea Technologies

Mauna Kea Technologies is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases thanks to real time in vivo microscopic visualization. The Company's flagship product, Cellvizio®, has received clearance/approval for a wide range of applications in the United States and more than 40 countries around the World. For more information on Mauna Kea Technologies, visit www.maunakeatech.com

United States
Mike Piccinino, CFA
Westwicke, an ICR Company
443-213-0500

France and Europe NewCap - Investor Relations Thomas Grojean +33 (0)1 44 71 94 94 maunakea@newcap.eu

Disclaimer

This press release contains forward-looking statements concerning Mauna Kea Technologies and its activities. Such forward looking statements are based on assumptions that Mauna Kea Technologies considers to be reasonable. However, there can be no assurance that the anticipated events contained in such forward-looking statements will occur. Forward- looking statements are subject to numerous risks and uncertainties including the risks set forth in the Universal Registration Document of Mauna Kea Technologies registered by the French Financial Markets Authority (Autorité des marchés financiers (AMF)) on August 7, 2020 under number 926346434_20200807 and available on the Company's website (www.maunakeatech.com), and to the development of economic situation, financial markets, and the markets in which Mauna Kea Technologies operates. The forward-looking statements contained in this release are also subject to risks unknown to Mauna Kea Technologies or that Mauna Kea Technologies does not consider material at this time. The realization of all or part of these risks could lead to actual results, financial conditions, performances or achievements by Mauna Kea Technologies that differ significantly from the results, financial conditions, performances or achievements expressed in such forward-looking statements. This press release and the information it contains do not constitute an offer to sell or to subscribe for, or a solicitation of an order to purchase or subscribe for, Mauna Kea Technologies shares in any country.